Bill > H2185

This bill aims to ensure access to generic medications by regulating how pharmacy benefit managers (PBMs) and covered entities can use "maximum allowable cost lists" to reimburse pharmacies. The key provisions include: requiring drugs on these lists to be FDA-approved as therapeutically equivalent; mandating that PBMs and covered entities provide pharmacies with the sources used to determine maximum allowable costs and update the lists regularly; establishing a process for pharmacies to contest maximum allowable costs that are below the actual purchase price; and prohibiting pharmacies from disclosing the maximum allowable cost lists to third parties, with some exceptions.

Business and Industry

https://malegislature.gov/Bills/190/H2185